Perspective Therapeutics (CATX) EBT Margin (2010 - 2023)

Perspective Therapeutics (CATX) has 14 years of EBT Margin data on file, last reported at 158.57% in Q4 2023.

• For the quarter ending Q4 2023, EBT Margin changed N/A year-over-year to 158.57%; the trailing twelve-month figure through Dec 2023 stood at 4456.5% (changed N/A YoY), and the FY2023 full-year result was 2796.79%, changed N/A from the prior year.
• EBT Margin climbed to 158.57% in Q4 2023, from 438.08% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 158.57% in Q4 2023 to a low of 632.4% in Q2 2023.
• A 5-year average of 121.91% and a median of 59.2% in 2019 frame the typical range for EBT Margin.
• Across the five-year window, EBT Margin soared 9319 bps in 2019 and slumped 56915 bps in 2023, its largest moves.
• Tracing CATX's EBT Margin over 5 years: stood at 59.61% in 2019, then increased by 19 bps to 47.99% in 2020, then dropped by 19 bps to 56.96% in 2021, then slumped by 84 bps to 105.06% in 2022, then jumped by 251 bps to 158.57% in 2023.
• Business Quant data shows CATX's EBT Margin at 158.57% in Q4 2023, 438.08% in Q3 2023, and 632.4% in Q2 2023.